Related Experiment Video

Updated: Jul 16, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statin therapy: not just used to lower cholesterol?

Lisha Kronmann1, Chad Hatfield, Karl Kronmann

  • 1Scripps Mercy Hospital/CardinalHealth, San Diego, California 92103, USA. knonmann.lisha@scrippshealth.org

Critical Care Nursing Quarterly
|March 16, 2007
PubMed

Insights

Statins, or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are key for hyperlipidemia. Emerging evidence supports their use in acute coronary syndrome, percutaneous coronary intervention, and sepsis prevention.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Biochemistry

Background:

  • 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are primary treatments for hyperlipidemia.
  • Statins are proven to reduce cholesterol and slow atherosclerosis.
  • Beyond lipid-lowering, statins possess pleiotropic effects suggesting broader therapeutic potential.

Purpose of the Study:

  • To review evidence for novel applications of statins.
  • To explore statin utility in acute coronary syndrome (ACS).
  • To examine statins as adjuncts in percutaneous coronary intervention (PCI) and for sepsis prevention.

Main Methods:

  • Literature review of existing studies and evidence.
  • Analysis of clinical trial data and observational studies.
  • Discussion of the pharmacological rationale for expanded statin use.

Main Results:

  • Evidence supports statin use in managing acute coronary syndrome.
  • Statins show promise as adjunctive therapy in percutaneous coronary intervention.
  • Preliminary data suggests potential benefits of statins in sepsis prevention.

Conclusions:

  • Statins demonstrate efficacy beyond hyperlipidemia management.
  • Further research into statin-eluting stents is warranted.
  • Pleiotropic effects of statins open avenues for new therapeutic strategies.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...